Business
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...
Hi, what are you looking for?
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...
– Teva CSO Dr. Michael Hayden: We are disappointed with these results. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) today announced...
– Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan. – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company...
– Hyperion Therapeutics (Nasdaq:HPTX) announced today that it acquires Andromeda Biotech Ltd., an Israel-based subsidiary of Clal Biotechnology Industries Ltd. (TASE:CBI), for $20 million...
– – Dr. Phillip Frost’s , Opko Health (NYSE: OPK) , revealed that it agreed to pay $10 million for the Israeli Inspiro Medical, a next...
– Inspiromatic Improves Drug Delivery, Monitors Patient Inhalation and Provides Real-Time Patient Feedback. – – OPKO Health, Inc. (NYSE:OPK) has entered into a definitive...
– The stem cell developer could be acquired at a company value of hundreds of millions of dollars. – Stem cell therapies developer Gamida-Cell...
– Sales of Protalix’s Gaucher’s disease drug to Pfizer totaled $4.4 million in 2013. – – Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE: PLX) is not yet seeing...
– Perrigo Company plc Announces Acquisition Of OTC Products In Australia – Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket...
– – On Friday Latvian pharmaceuticals manufacturer the Grindeks Group announced its preliminary, and still unaudited, financial statements for its latest fiscal year ended...